- DIAGNOSIS AND MANAGEMENT OF LOW-GRADE DYSPLASIA IN BARRETT S . . .
Refer patients with Barrett’s esophagus-related neoplasia, including patients diagnosed with low-grade dysplasia and indefinite for dysplasia to high volume endoscopists with expertise in endoscopic eradication therapy, pathologists with expertise in BE neoplasia and access to multi-disciplinary care
- Barrett Esophagus: Rapid Evidence Review - AAFP
Barrett esophagus is a premalignant change of the esophagus; however, malignant transformation to esophageal adeno-carcinoma is rare in patients without dysplasia Barrett esophagus is estimated
- FAQS: BARRETT’S ESOPHAGUS (WITH OR WITHOUT DYSPLASIA)
The esophagus is a tubular organ that connects the mouth to the stomach GEJ means “Gastro-esophageal junction,” which is where the esophagus meets the stomach 2 What does it mean if my report mentions the terms “Barrett’s”, “goblet cells”, or “intestinal metaplasia”? The lining of the esophagus is known as the “mucosa ”
- ASGE guideline on screening and surveillance of Barretts . . .
This document is the official American Society for Gastrointestinal Endoscopy guideline on screening and surveillance in patients with Barrett’s esophagus (BE) and is based on systematic reviews of the evidence using the Grading of Recommendations, Assessment, Develop-ment and Evaluation methodology The document ad-dresses key clinical questions that include the role and impact of screening
- Barrett’s Esophagus and Barrett’s-Related Dysplasia
The ability to target those patients with Barrett’s esophagus who are at much greater risk for progressing to dysplasia or carcinoma would be highly valued by gastroen-terologists, pathologists and, most important, pa-tients with long-standing gastroesophageal reflux disease and known intestinal metaplasia
- ACG Clinical Guideline: Diagnosis and Management of Barrett’s . . .
The diagnosis of GERD is associated with a 10–15% risk of Barrett’s esophagus (BE), a change of the normal squamous epithelium of the distal esophagus to a columnar-lined intestinal metaplasia (IM) Risk factors associated with the development of BE include long-standing GERD, male gender, central obesity (3), and age over 50 years (4,5)
- The Society of Thoracic Surgeons Practice Guideline Series . . .
Progression of metaplasia through dysplasia to adeno-carcinoma is a widely accepted theory of esophageal carcinogenesis [2, 3] It is also known that most patients with Barrett’s or low-grade dysplasia will not progress to invasive cancer
|